Leaflet RIFONAT 30mg / ml concentrate for solution for infusion


Indicated for: bacterial infections

Route of administration: infusion

Substance: rifamycin (antibacterial antibiotic)

ATC: J04AB03 (Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics)

Rifamycin is an antibiotic from the rifamycin class, primarily used to treat bacterial intestinal infections, such as traveler’s diarrhea caused by bacteria like Escherichia coli. It works locally in the intestine by inhibiting bacterial RNA synthesis, leading to bacterial destruction.

One advantage of rifamycin is its minimal absorption into the bloodstream, which reduces the risk of systemic side effects. It is commonly used for mild to moderate bacterial infections of the gastrointestinal tract.

Rifamycin is generally well-tolerated but may cause side effects such as nausea, abdominal pain, or bloating. Patients should follow the prescribed treatment and avoid stopping the medication before completing the full course.

This medication is not effective against viral infections and should not be used without a specialist’s recommendation.

General data about RIFONAT 30mg / ml

  • Substance: rifamycin
  • Date of last drug list: 01-06-2016
  • Commercial code: W60581001
  • Concentration: 30mg / ml
  • Pharmaceutical form: concentrate for solution for infusion
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).